Following the FDA’s approval Monday of its muscular dystrophy drug, Cambridge, Mass.-based Sarepta Therapeutics plans to sell up to $255 million of stock and use the proceeds to fund clinical trials, ...

Health tech company Waltz Health will merge with Eversana with the goal of shaking up access to prescription drugs. The deal will bring together Waltz's proprietary drug marketplaces and ...

SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients ...

Rosa explained the company will issue financial guidance for fiscal 2026 after receiving final projections from Zimmer Biomet. "We plan on providing financial guidance for fiscal year 2026 once we ...

NEW YORK, March 12, 2026 /PRNewswire/ -- Medical Knowledge Group (MKG) today announced the appointment of David Margines to its Board of Directors. The move deepens the company's commitment to AI- and ...

China Medical System Holdings Limited ('CMS” or the 'Group”) is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive commercialization and supply agreement ...

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced a discovery ...

Last month, the US Food and Drug Administration (FDA) approved two new drugs and two biosimilars as well as halted commercialization for a hemophilia treatment. Here’s a deeper look of what happened ...

VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

Kevin Sabet, Smart Approaches to Marijuana CEO, former White House drug policy advisor and ‘One Nation Under Influence’ author, joins 'Squawk Box' to discuss President Trump's executive order to ...